203 related articles for article (PubMed ID: 10563168)
1. [PSA-based screening for prostatic cancer].
Johansen TE
Tidsskr Nor Laegeforen; 1999 Oct; 119(24):3550. PubMed ID: 10563168
[No Abstract] [Full Text] [Related]
2. [Timely screening routines for prostatic cancer by Norwegian physicians].
Fosså SD; Eri LM
Tidsskr Nor Laegeforen; 1999 Oct; 119(24):3572-6. PubMed ID: 10563174
[TBL] [Abstract][Full Text] [Related]
3. Editorial. PSA screening and low risk prostate cancer, what's going on? are we shooting the messenger?
Martínez-Salamanca JI
Arch Esp Urol; 2012 Mar; 65(2):209-14. PubMed ID: 22414449
[No Abstract] [Full Text] [Related]
4. Prostate-specific antigen and screening for prostate cancer.
Han M; Gann PH; Catalona WJ
Med Clin North Am; 2004 Mar; 88(2):245-65, ix. PubMed ID: 15049577
[TBL] [Abstract][Full Text] [Related]
5. How important are the prostate-specific antigen assays?
Vessella RL
Contemp Intern Med; 1994 Feb; 6(2):76-89. PubMed ID: 10146682
[No Abstract] [Full Text] [Related]
6. Comparison of preoperative prostate specific antigen density and prostate specific antigen for predicting recurrence after radical prostatectomy: results from the search data base.
Freedland SJ; Kane CJ; Presti JC; Terris MK; Amling CL; Dorey F; Aronson WJ
J Urol; 2003 Mar; 169(3):969-73. PubMed ID: 12576824
[TBL] [Abstract][Full Text] [Related]
7. [Use of prostate specific antigen. A review].
Brasso K; Skaarup P; Roosen JU; Iverson P
Ugeskr Laeger; 1998 Jul; 160(31):4510-6. PubMed ID: 9700305
[TBL] [Abstract][Full Text] [Related]
8. The Japanese guideline for prostate cancer screening.
Hamashima C; Nakayama T; Sagawa M; Saito H; Sobue T
Jpn J Clin Oncol; 2009 Jun; 39(6):339-51. PubMed ID: 19346535
[TBL] [Abstract][Full Text] [Related]
9. What PCPs and geriatricians need to know about robotic prostatectomy and organ-confined prostate cancer.
Carlucci JR; Nabizada-Pace F; Samadi DB
Geriatrics; 2009 Feb; 64(2):8-14. PubMed ID: 19256581
[TBL] [Abstract][Full Text] [Related]
10. Preoperative serum prostate specific antigen levels between 2 and 22 ng./ml. correlate poorly with post-radical prostatectomy cancer morphology: prostate specific antigen cure rates appear constant between 2 and 9 ng./ml.
Stamey TA; Johnstone IM; McNeal JE; Lu AY; Yemoto CM
J Urol; 2002 Jan; 167(1):103-11. PubMed ID: 11743285
[TBL] [Abstract][Full Text] [Related]
11. PSA screening for asymptomatic prostate cancer: truth in advertising.
Hahn DL; Roberts RG
J Fam Pract; 1993 Nov; 37(5):432-6. PubMed ID: 7693858
[No Abstract] [Full Text] [Related]
12. Early detection of prostate cancer with low PSA cut-off values leads to significant stage migration in radical prostatectomy specimens.
Berger AP; Spranger R; Kofler K; Steiner H; Bartsch G; Horninger W
Prostate; 2003 Oct; 57(2):93-8. PubMed ID: 12949932
[TBL] [Abstract][Full Text] [Related]
13. [Practice guideline 'Prostate cancer: diagnosis and treatment'].
Giard RW
Ned Tijdschr Geneeskd; 2008 Sep; 152(38):2099-100; author reply 2100. PubMed ID: 18837188
[No Abstract] [Full Text] [Related]
14. What to do with an abnormal PSA test.
Loeb S; Catalona WJ
Oncologist; 2008 Mar; 13(3):299-305. PubMed ID: 18378540
[TBL] [Abstract][Full Text] [Related]
15. Update on screening for prostate cancer with prostate-specific antigen.
Schmid HP; Riesen W; Prikler L
Crit Rev Oncol Hematol; 2004 Apr; 50(1):71-8. PubMed ID: 15094160
[TBL] [Abstract][Full Text] [Related]
16. Screening for prostate cancer: updated experience from the Tyrol study.
Horninger W; Berger A; Pelzer A; Klocker H; Oberaigner W; Schönitzer D; Severi G; Robertson C; Boyle P; Bartsch G
Can J Urol; 2005 Feb; 12 Suppl 1():7-13; discussion 92-3. PubMed ID: 15780158
[TBL] [Abstract][Full Text] [Related]
17. Ki-67 in screen-detected, low-grade, low-stage prostate cancer, relation to prostate-specific antigen doubling time, Gleason score and prostate-specific antigen relapse after radical prostatectomy.
Khatami A; Hugosson J; Wang W; Damber JE
Scand J Urol Nephrol; 2009; 43(1):12-8. PubMed ID: 18949633
[TBL] [Abstract][Full Text] [Related]
18. Obesity and oncological outcome after radical prostatectomy: impact of prostate-specific antigen-based prostate cancer screening: results from the Shared Equal Access Regional Cancer Hospital and Duke Prostate Center databases.
Freedland SJ; Sun L; Kane CJ; Presti JC; Terris MK; Amling CL; Moul JW; Aronson WJ
BJU Int; 2008 Sep; 102(8):969-74. PubMed ID: 18691175
[TBL] [Abstract][Full Text] [Related]
19. Prostate-specific antigen kinetics in screen-detected prostate cancer in Japan.
Takechi H; Ito K; Yamamoto T; Miyakubo M; Ohi M; Suzuki K
Urology; 2008 Nov; 72(5):1111-5. PubMed ID: 18342926
[TBL] [Abstract][Full Text] [Related]
20. Screening for prostate cancer. Surgery lengthens survival.
Hodgson WB
BMJ; 1998 Jun; 316(7148):1903-4. PubMed ID: 9669857
[No Abstract] [Full Text] [Related]
[Next] [New Search]
